|
Schmelzle, Moritz; Splith, Katrin; Andersen, Lars W et al. (2013) Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. Transplantation 95:63-9
|
|
O'Keeffe, Mary G; Thorne, Peter R; Housley, Gary D et al. (2012) Hair cell specific NTPDase6 immunolocalisation in vestibular end organs: potential role of purinergic signaling in vestibular sensory transduction. J Vestib Res 22:213-9
|
|
Deaglio, Silvia; Robson, Simon C (2011) Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 61:301-32
|
|
Cowan, Peter J; Robson, Simon C; d'Apice, Anthony J F (2011) Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 16:214-21
|
|
Feng, Lili; Sun, Xiaofeng; Csizmadia, Eva et al. (2011) Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 13:206-16
|
|
Crikis, S; Zhang, X M; Dezfouli, S et al. (2010) Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice. Am J Transplant 10:242-50
|
|
Crikis, S; Lu, B; Murray-Segal, L M et al. (2010) Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant 10:2586-95
|
|
Beldi, Guido; Banz, Yara; Kroemer, Alexander et al. (2010) Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. Hepatology 51:1702-11
|
|
Friedman, David J; Künzli, Beat M; A-Rahim, Yousif I et al. (2009) From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 106:16788-93
|
|
Braganhol, Elizandra; Morrone, Fernanda B; Bernardi, Andressa et al. (2009) Selective NTPDase2 expression modulates in vivo rat glioma growth. Cancer Sci 100:1434-42
|
Showing the most recent 10 out of 53 publications
